To investigate this, we utilized statin drugs to inhibit the SREBP‐HMGCR axis and conducted in vitro studies on representative germinal center B‐cell (GCB) and activated B‐cell (ABC) subtypes of diffuse large B‐cell lymphoma (DLBCL) cell lines. Here, HMGCR is linked to diffuse large B-cell lymphoma.